-

Verilife Opens New Dispensary in Plymouth Meeting, Pennsylvania

Newest Verilife Dispensary To Celebrate Grand Opening November 6th

Launches Pennsylvania Expansion

PHILADELPHIA--(BUSINESS WIRE)--PharmaCann Inc., one of the nation’s largest privately held vertically integrated cannabis companies, announced today the opening of its newest Verilife location in Plymouth Meeting, Pennsylvania. This will mark the company’s fifth Pennsylvania dispensary.

“As we expand in Pennsylvania, we are pleased to broaden our service to new patients and communities starting with the addition of our newest Verilife location in Plymouth Meeting,” said Bill McMenamy, President of Verilife. “Our team is committed to ensuring all patients across Pennsylvania communities have access to our diverse menu of products that allows them to improve their lives through cannabis.”

To serve additional communities across Pennsylvania, PharmaCann has plans, pending final regulatory approval, to open new Verilife dispensary locations in Lancaster, Quakertown, and Pottstown. This expansion will add to the existing Verilife locations in Chester, Manayunk, Williamsport and Shamokin.

Verilife Plymouth Meeting is located at 601 W Germantown Pike and will be open seven days a week for Pennsylvania medical marijuana patients and caregivers. Visit www.verilife.com/pa for details.

About Verilife

PharmaCann Inc. operates its dispensaries under the name Verilife. Verilife is committed to helping people feel better and live better by dispelling outdated perceptions associated with cannabis and encouraging a new appreciation of its many benefits. For more information, please visit www.verilife.com.

About PharmaCann

PharmaCann Inc. one of the nation’s largest privately held, vertically integrated cannabis companies, providing safe, reliable, and high-quality cannabis products to people in both the medical and adult-use markets. The PharmaCann geographic footprint includes dispensaries and cultivation and processing operations in six states. For more information about PharmaCann, please visit www.pharmacann.com.

Contacts

Beth Coronelli
312-667-6260 ext. 322019
media@pharmacann.com

PharmaCann Inc.


Release Versions

Contacts

Beth Coronelli
312-667-6260 ext. 322019
media@pharmacann.com

More News From PharmaCann Inc.

PharmaCann and LivWell Enlightened Health Announce Completion of Merger

CHICAGO & DENVER--(BUSINESS WIRE)--PharmaCann Inc., one of the nation’s largest privately held, vertically integrated cannabis companies, and LivWell Enlightened Health, a multi-state cannabis cultivation and retail leader based in Colorado, today announced the completion of their previously disclosed definitive merger agreement for PharmaCann to acquire LivWell Holdings, Inc. “The combination of PharmaCann and LivWell is a natural fit given our shared commitment to improving people’s lives thr...

PharmaCann Completes $40 Million Additional Issuance of Senior Secured Notes

CHICAGO--(BUSINESS WIRE)--PharmaCann Inc. (“PharmaCann” or the “Company”), one of the largest, private, vertically integrated cannabis companies in the United States, today announced that it has completed an additional issuance of 12% Senior Secured Notes due June 30, 2025 (the “Notes”). The net proceeds from the upsize were approximately $39.5 million, after the original issue discount and other estimated offering expenses, and will be used for strategic growth opportunities and general corpor...

Verilife Dispensaries to Offer First Whole Flower in the Market to Patients Across Multiple New York Locations on October 26th

CHICAGO--(BUSINESS WIRE)--PharmaCann Inc. (“PharmaCann”), the largest privately held, vertically integrated cannabis company in the United States, announced its Verilife dispensaries in Albany and Bronx, New York, are now offering whole flower under the “matter” brand as of today, October 26th, and whole flower will be available in its Amherst and Liverpool locations tomorrow, October 27th. “We are pleased to bring patients the first whole flower for sale in the State of New York across multipl...
Back to Newsroom